| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.065 | 25.243 | 26.335 | 28.018 | 19.124 | 24.648 | 27.186 | 26.796 | 30.680 | 34.456 |
| Total Income - EUR | 23.065 | 25.273 | 26.335 | 28.018 | 19.204 | 24.908 | 27.202 | 26.797 | 30.680 | 34.456 |
| Total Expenses - EUR | 26.237 | 26.434 | 25.868 | 25.635 | 21.386 | 23.939 | 27.066 | 28.803 | 30.217 | 31.366 |
| Gross Profit/Loss - EUR | -3.171 | -1.161 | 467 | 2.384 | -2.182 | 969 | 136 | -2.005 | 463 | 3.090 |
| Net Profit/Loss - EUR | -3.863 | -1.414 | 204 | 2.103 | -2.374 | 740 | -136 | -2.276 | 156 | 2.057 |
| Employees | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Verodent 94 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 144 | 250 | 660 | 1.534 | 1.123 | 541 | 1.427 | 152 | 1.244 | 3.176 |
| Inventories | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Receivables | 95 | 94 | 530 | 151 | 148 | 215 | 0 | 0 | 0 | 99 |
| Cash | 49 | 156 | 130 | 1.380 | 973 | 324 | 1.425 | 150 | 1.242 | 3.075 |
| Shareholders Funds | -3.580 | -4.957 | -4.669 | -2.480 | -4.806 | -3.975 | -4.220 | -6.509 | -6.333 | -4.241 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.724 | 5.207 | 5.330 | 4.014 | 5.929 | 4.516 | 5.647 | 6.661 | 7.577 | 7.417 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Verodent 94 Srl